Certara | Investor Day Presentation Deck | 91 slides

Certara · 2021-12
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 5
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

91
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
front_matter
Open slide detailBeat · Attention
04
The slide uses a photo of the company leadership team at the Nasdaq opening bell ceremony.front_matter
Open slide detailBeat · Attention
05
summarize
Open slide detailBeat · Attention
06
The slide uses a stepped process diagram to map software solutions to specific stages of the R&D lifecycle.present_framework
07
present_solution
08
The slide uses a Vitruvian-man style anatomical diagram to map specific organ models.establish_context
09
present_solution
10
The chart shows revenue growth from $178.9M to $210.8M, with regional breakdowns for Americas, EMEA, and Asia Pac.analyze_data
11
The chart uses a Venn-like overlapping circle design to show market growth.size_opportunity
12
frame_problem
Open slide detailBeat · NeedLoop · Cost Of Inaction
13
The diagram is a circular process model representing a flywheel.present_framework
Open slide detailBeat · NeedLoop · Cost Of Inaction
14
The slide uses a grid of icons to represent different software products.present_solution
Open slide detailBeat · NeedLoop · Cost Of Inaction
15
The diagram is a circular process flow representing a flywheel.present_framework
Open slide detailBeat · NeedLoop · Cost Of Inaction
16
The chart shows a clear upward trend in the number of FDA guidances incorporating biosimulation from <2000 to 2020.analyze_data
Open slide detailBeat · NeedLoop · Cost Of Inaction
17
The slide uses a circular process diagram to represent a flywheel effect.present_framework
Open slide detailBeat · NeedLoop · Cost Of Inaction
18
The chart shows a steady increase in publications, with a notable rise in PBPK (yellow) in later years.analyze_data
Open slide detailBeat · NeedLoop · Cost Of Inaction
19
The slide uses a circular process diagram to represent a flywheel.present_framework
Open slide detailBeat · NeedLoop · Cost Of Inaction
20
The slide uses a bar chart for historical data and a word cloud for 2021 examples.summarize
Open slide detailBeat · NeedLoop · Cost Of Inaction
21
present_solution
Open slide detailBeat · Satisfaction
22
The slide serves as a team introduction or culture slide.other
Open slide detailBeat · Satisfaction
23
The slide uses a background image of employees and a map overlay to illustrate global presence.other
Open slide detailBeat · Satisfaction
24
The slide uses a stepped process diagram to illustrate strategic pillars.present_solution
Open slide detailBeat · Satisfaction
25
introduce_nominees
Open slide detailBeat · Satisfaction
26
front_matter
Open slide detailBeat · Satisfaction
27
The slide uses a dashboard-style layout with three primary KPIs (Revenue, Bookings, Renewal Rate) and a sidebar for qualitative 2021 highlights.analyze_data
Open slide detailBeat · Satisfaction
28
summarize
Open slide detailBeat · Satisfaction
29
The slide features a photo of the Certara/Simcyp office environment.front_matter
Open slide detailBeat · Satisfaction
30
The diagram uses a ribbon-like process flow over a base arrow representing the platform.present_framework
Open slide detailBeat · Satisfaction
31
The slide illustrates the ADME process (Absorption, Distribution, Metabolism, Excretion) in a human body diagram.present_solution
Open slide detailBeat · Satisfaction
32
The slide uses a circular segment diagram to contrast QSP and PBPK.present_framework
Open slide detailBeat · Satisfaction
33
The slide uses a pie chart to categorize drug-body interaction types and a diagram to illustrate the mechanism of action.present_framework
Open slide detailBeat · Satisfaction
34
The diagram is a circular hub-and-spoke model representing the platform's core competencies and application areas.summarize
Open slide detailBeat · Satisfaction
35
establish_context
Open slide detailBeat · Satisfaction
36
The chart shows a clear upward trend in scientific publications from 2008 to 2021.summarize
Open slide detailBeat · Satisfaction
37
The slide serves as a proof-point/evidence matrix for the efficacy and adoption of the Simcyp Simulator in the pharmaceutical industry.illustrate_case
Open slide detailBeat · Satisfaction
38
The slide highlights the methodology (Simcyp Simulator) and the clinical outcome (labeling changes for LUPKYNIS).analyze_data
Open slide detailBeat · Satisfaction
39
summarize
Open slide detailBeat · Satisfaction
40
Includes a diagram of PBPK model applications and a specific research highlight for Diclofenac Sodium Topical Gel.illustrate_case
Open slide detailBeat · Satisfaction
41
The slide uses a circular diagram to segment three distinct areas of biosimulation.present_framework
42
The slide uses a horizontal arrow to denote a progression of complexity across five distinct medical domains.present_framework
43
The slide features a screenshot of a software interface showing a heatmap-style matrix of compounds vs receptors.present_solution
44
The slide uses a background photo of a workshop or training session.front_matter
45
The slide shows a PBPK (Physiologically Based Pharmacokinetic) modeling framework.present_framework
46
The slide uses a process flow to map specific R&D activities to three stages of drug development, supported by a 'Learn and confirm' iterative modeling concept.present_framework
47
The slide outlines a three-step process for pharmaceutical modeling.present_framework
48
The chart uses a logarithmic scale for the x-axis (Ratio with 95% confidence interval).analyze_data
49
The slide cites an FDA label report from 2013 as a precedent for using PBPK modeling in regulatory decision-making.cite_precedent
50
The slide uses a combination of a milestone list and a three-stage temporal progression (Yesterday, Today, Tomorrow).summarize
51
The slide uses a ribbon-like process diagram to show the stages of drug development.transition
52
The slide uses a linear process flow to frame the clinical data workflow.diagnose_problem
53
The slide uses a process flow to map pain points to specific stages of the clinical data workflow.diagnose_problem
54
The slide highlights the Pinnacle 21 Integral Repository as part of the clinical data workflow.present_solution
55
The slide highlights the adoption of Pinnacle 21 by FDA/PMDA and top biopharma companies, alongside a visual representation of a data quality scoring system.summarize
56
The slide maps specific company platforms (Pinnacle 21, Phoenix, Integral, Simcyp) to stages in the clinical data workflow.present_solution
57
The slide uses a hub-and-spoke diagram to represent the software ecosystem.present_solution
58
The slide highlights the 'Regulatory Content and Submission' stage as the focal point of the workflow.present_solution
59
The slide illustrates a feedback loop between clinical studies and regulatory agencies, with Certara's software products mapped to each stage of the process.present_framework
60
The diagram uses a temple-like structure to represent a vision supported by operational pillars and specific data workflows.present_framework
61
The slide features a photograph of a business meeting in progress with the title and speaker names overlaid on a semi-transparent white box.front_matter
Open slide detailLoop · Quick Win Big Bet
62
The slide uses a combination of big-number circles for financial metrics and a sidebar for qualitative/quantitative operational highlights.analyze_data
Open slide detailLoop · Quick Win Big Bet
63
summarize
Open slide detailLoop · Quick Win Big Bet
64
present_solution
Open slide detailLoop · Quick Win Big Bet
65
frame_problem
Open slide detailLoop · Quick Win Big Bet
66
The slide uses a pyramid diagram to illustrate the hierarchy of data sources and the resulting strategic applications.summarize
Open slide detailLoop · Quick Win Big Bet
67
The chart is a forest plot comparing odds ratios. The slide also references an FDA guidance document.analyze_data
Open slide detailLoop · Quick Win Big Bet
68
The slide uses cumulative meta-analysis plots to show how evidence evolves over time for Anti-Interleukin-6 and Glucocorticoids.analyze_data
Open slide detailLoop · Quick Win Big Bet
69
The slide uses a hub-and-spoke diagram to represent service offerings, with 'Lift and Shift' encompassing a broader scope of 'Drug development & regulatory strapresent_framework
Open slide detailLoop · Quick Win Big Bet
70
present_framework
Open slide detailLoop · Quick Win Big Bet
71
The slide highlights a successful partnership outcome, listing specific services provided and key achievements.illustrate_case
Open slide detailLoop · Quick Win Big Bet
72
The slide highlights a successful outcome (FDA approval) and the specific services provided.illustrate_case
Open slide detailLoop · Quick Win Big Bet
73
illustrate_case
Open slide detailLoop · Quick Win Big Bet
74
The slide highlights organizational growth and culture through metrics and visual evidence.summarize
Open slide detailLoop · Quick Win Big Bet
75
summarize
Open slide detailLoop · Quick Win Big Bet
76
transition
Open slide detailLoop · Quick Win Big Bet
77
front_matter
Open slide detailBeat · Action
78
The slide uses a circular layout for primary metrics and a table-like row for YoY changes.analyze_data
Open slide detailBeat · Action
79
TTM = Trailing Twelve Months. Data points: 2020 (73.9, 198.2, 272.1), 2021 (85.6, 236.5, 322.1).analyze_data
Open slide detailBeat · Action
80
The slide provides a snapshot of an M&A transaction, highlighting key financial metrics and market positioning.analyze_data
Open slide detailBeat · Action
81
Mentions early adoption for fiscal year 2021 and the discontinuation of the 'Adjusted Revenue' metric.summarize
Open slide detailBeat · Action
82
Includes disclaimer regarding non-GAAP reconciliation and specific accounting adjustments for M&A.summarize
Open slide detailBeat · Action
83
The slide uses a photo of the team at the Nasdaq as a background, with a semi-transparent overlay for text.summarize
Open slide detailBeat · Action
84
The slide uses a ribbon-style timeline diagram to categorize offerings.present_solution
Open slide detailBeat · Action
85
The slide uses a vertical timeline-style list to present key investment points.summarize
Open slide detailBeat · Action
86
front_matter
Open slide detailBeat · Action
87
appendix
Open slide detailBeat · Action
88
Standard financial disclosure table for non-GAAP metrics.analyze_data
Open slide detailBeat · Action
89
Standard financial disclosure table for non-GAAP metrics.analyze_data
Open slide detailBeat · Action
90
Includes footnotes (a) through (l) referenced in the table rows.analyze_data
Open slide detailBeat · Action
91
This slide provides the definitions for the lettered footnotes typically found in financial reconciliation tables.appendix
Open slide detailBeat · Action